(86) transfected the adenovirus vector harboring B2M gene (AdCMVB2M) into MHC-I negative/B2M-deficient malignant tumor (melanoma, colorectal cancer, prostate cancer) cell lines. This evidence concerns the gene B2M and prostate carcinoma.